Vexenat J A, Croft S L, Furtado Campos J H, Miles M A
Medical Parasitology Laboratory, University of Brasilia, Brasilia DF, Brazil.
Vet Parasitol. 1998 May;77(1):71-3. doi: 10.1016/s0304-4017(96)01150-8.
Buparvaquone (Butalex), a therapeutic for theileriosis, has been shown to have anti-leishmanial activity in vitro. Seven dogs with symptomatic, parasitologically positive, canine visceral leishmaniosis were treated with Butalex at 5 mg kg(-1) body weight using four doses over 12 days. Two animals showed minor clinical improvement (growth of healthy hair) but all remained parasitologically positive and disease progression was not halted.
